Collaboration
Where KeepBio is focusing first
ICU Patients receiving broad-spectrum antibiotics present an opportunity to demonstrate microbiome restoration as a strategy for supporting the microbiome’s natural protective function.
CRITICAL CARE
HEMATOLOGY & ONCOLOGY
Patients undergoing intensive treatment for leukemia and other hematologic conditions frequently experience significant antibiotic exposure and microbiome disruption.
Partner with KeepBio to advance the science
KeepBio is seeking collaborations with hospitals, investigators, and clinical research organizations interested in studying microbiome restoration in vulnerable patient populations.
We welcome discussions about clinical studies, translational research, and real-world evidence generation in all patients with pathogen-dominated conditions.
PROTECTED INNOVATION
Building a defensible microbiome platform
KeepBio’s technology and development approach are protected through a combination of patents and proprietary trade secrets, creating intellectual property protection around key elements of the platform and its application.